EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Long-Term Safety of Combination Products Incorporating Emerging Platform Technologies: Considerations for Gene Therapies, Immuno-Oncology Platforms, and Other Novel Modalities
Advanced modalities are reshaping longterm safety expectations by extending the risk horizon beyond early tolerability and shortterm adverse event review Gene therapies immunooncology platforms and other novel technologies may introduce delayed persistent immunemediated or cumulative toxicities that emerge
Advisory Board
KNOWLEDGE BANK
-
Articles
Revolutionizing Healthcare with Innovative Therapeutics
Revolutionizing healthcare with innovative therapeutics involves the development and application of groundbreaking treatments and approaches that significantly improve patient outcomes reduce costs and enhance overall healthcare effectiveness
Personalized Medicine and Longevity: Advancing the Frontier
The world is experiencing a profound demographic shift with population aging impacting healthcare economies and human rights The United Nations projects that by the number of people aged and over will double to billion comprising one in six people worldwide United Nations OHCHR By older adults will likely outnumber children necessitating a rethink of health aging and longevity Hartmann Young
What Are the Benefits of Implementing a Modern MES in Pharma?
The pharmaceutical sector is rapidly changing in a bid to match the increasing pressure of regulation attain perfection in product quality and hasten the timetomarket A Pharma MES or Manufacturing Execution System is one of the most strategic investments that are strategically placed in this environment in terms of operational excellence
Biopharmaceutical Facility Design for Sustainability: A Comprehensive Overview
The design and operation of biopharmaceutical facilities play a pivotal role in shaping the environmental impact of the pharmaceutical industry In recent years there has been a growing emphasis on sustainability within this sector
Data Security Challenges in Pharma IT: Safeguarding Sensitive Information
The pharmaceutical industry faces several data security challenges in its IT infrastructure primarily related to safeguarding sensitive information The nature of the data regulatory requirements and the increasing sophistication of cyber threats
The Competitive Generic Therapy (CGT)
Generic medications are critical in the healthcare sector due to their affordability and accessibility to the public while maintaining comparable quality efficacy and safety to that of branded products Generic medications research and development followed by commercialisation also fosters competition and innovation within the pharmaceutical
-
Techno Trends
FDA Approves Regeneron’s First-in-Class Gene Therapy for OTOF Hearing Loss
Regeneron Pharmaceuticals has received FDA accelerated approval lunsotogene parveccwha a gene therapy for patients with severetoprofound sensorineural hearing loss caused by OTOF gene mutations
-
Projects
Boehringer Ingelheim Invests £150 Million to Expand Global AI Footprint in the UK
Boehringer Ingelheim is expanding its global Computational Innovation network with a new artificial intelligence AI and machine learning ML centre in Kings Cross London
-
Research Insights
Evaluation and enhancement of suspected opioid overdose definitions in emergency medical services data using machine learning with natural language processing
Fatal and nonfatal drug overdoses have evolved into a critical public health crisis with over a increase in the rate of fatal drug overdose since Emergency Medical Services EMS data has advantages
-
whitepaper
Placing the Right Bets: Defining Tailored Investment Strategies for Pharma Launch
Pharmaceutical launches have become significantly harder to execute successfully As IQVIAs new white paper highlights median six month cumulative sales for innovative launches have declined by compared with pre levels reflecting shrinking market opportunities
TOP ARTICLES
-
1
Personalized Medicine and Longevity: Advancing the Frontier
Dr. KaT Zarychta
Personalized medicine and longevity research are converging to advance healthcare frontiers. Innovations like genomic profiling, AI-driven diagnostics, and targeted interventions enable precision appr...
-
2
What Are the Benefits of Implementing a Modern MES in Pharma?
Kate Williamson
The modern MES will give the pharmaceutical manufacturing companies real-time visibility, automated compliance, and a smoothly integrated production control process. Pharma MES solutions promote effic...
-
3
Biopharmaceutical Facility Design for Sustainability: A Comprehensive Overview
Kate Williamson
This comprehensive overview explores the sustainable design of biopharmaceutical facilities, emphasizing key considerations such as green building design, energy efficiency, water conservation, waste...
-
4
Data Security Challenges in Pharma IT: Safeguarding Sensitive Information
Kate Williamson
The pharmaceutical sector encounters intricate data security challenges in its IT setup, encompassing data sensitivity, regulatory compliance, cybersecurity threats, supply chain risks, and insider th...
-
5
The Competitive Generic Therapy (CGT)
Raghunandhan Painoori
Dr. Naveen Chella
The Competitive Generic Therapy (CGT) Act, introduced by the US FDA in 2017 under the Generic Drug User Fee Act (GDUFA), aims to lower drug costs by promoting generics where competition is limited. It...
press releases Read more...
FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting
Roche announced today that the United States US Food and Drug Administration FDA has accepted the companys New Drug Application NDA under Priority Review for giredestrant an investigational oral selective
Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic
Decoy Therapeutics Inc a preclinicalstage biotechnology company pioneering a new category of antivirals today announced the execution of a strategic development initiative designed to support
Sino Biological’s Cell-Free Protein Synthesis Supports Tencent AI for Life Sciences Lab’s Protein Design Study Published in Nature Communications
Sino Biological Inc Shenzhen Stock Exchange SZ has announced that its gene synthesis and cellfree protein expression workflow was used in a recent study by Tencent AI for Life Sciences Lab published in Nature
T-CURX Acquires Pantherna Therapeutics to Accelerate Clinical Translation of its Non-Viral In Vivo CAR-T Strategies
Leading CART company TCURX announces the signing of a definitive agreement for the acquisition of Pantherna Therapeutics a German biotechnology company specializing in mRNA engineering and lipid nanoparticle LNP
Events Read more...
01 - 02
Jun 2026Future Pharma 2026
Renaissance Seaport District, Boston, MA, USA
02 - 04
Jun 2026CPHI Americas 2026
Pennsylvania Convention Center, Philadelphia, USA
04 - 05
Jun 2026Pharmac South 2026
Chennai Trade Centre, Nandambakkam, India
04 - 06
Jun 2026Global Bioprocessing Summit & Exhibition 2026
Berlin, Germany
09 - 11
Jun 20265th World ADC Summit South Korea
COEX Magok Lewest, 143 Magokjungang-ro, Gangseo-gu, Seoul, South Korea
09 - 11
Jun 2026World TPD & Induced Proximity Summit South Korea
COEX Magok Lewest, 143 Magokjungang-ro, Gangseo-gu, Seoul, South Korea
09 - 11
Jun 2026World Targeted Therapeutics Summit South Korea
COEX Magok Lewest, 143 Magokjungang-ro, Gangseo-gu, Seoul, South Korea
09 - 10
Jun 2026ChemE Show 2026
George R. Brown Convention Center, Houston, Texas, USA
LATEST NEWS Read more...
Haisco and Lilly Enter Research and Licensing Partnership for Innovative Medicines
Haisco Pharmaceutical Group Co Ltd has entered into a licensing and research collaboration with Eli Lilly and Company to develop innovative medicines across multiple therapeutic areas
Vertex Receives FDA Acceptance for Povetacicept Application in IgA Nephropathy
Vertex Pharmaceuticals has announced that the US Food and Drug Administration FDA has accepted its Biologics License Application BLA for povetacicept an investigational treatment for adults with immunoglobulin A nephropathy IgAN
FDA Grants Breakthrough Therapy Status to Merck’s Calderasib for KRAS G12C-Mutated NSCLC
Merck known as MSD outside the United States and Canada has received Breakthrough Therapy designation from the US Food and Drug Administration FDA for calderasib MK an investigational oral KRAS GC inhibitor
Innovent Biologics and Pfizer form global partnership for oncology drug development
Innovent Biologics and Pfizer have entered into a global strategic collaboration to develop earlystage and newly discovered cancer medicines The agreement covers the research and development of antibodydrug conjugates
Alzprotect receives FDA clearance for AZP2006 trial in PSP
Alzprotect has received clearance from the US Food and Drug Administration for its Investigational New Drug IND application for AZP Ezeprogind to treat Progressive Supranuclear Palsy PSP
CordenPharma to Acquire AmbioPharm to Expand Global Peptide API Capacity
CordenPharma has announced an agreement to acquire AmbioPharm a USbased peptide active pharmaceutical ingredient API contract development and manufacturing organisation CDMO








